IMMX - Immix Biopharma Inc
Immix Biopharma Inc Logo

IMMX - Immix Biopharma Inc

https://www.immixbio.com
Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of various tissue-specific therapies in oncology and inflammation in the United States and Australia. The company is headquartered in Los Angeles, California.

52W High
$3.20
52W Low
$1.26
MA Status:
50D: Below 200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.25
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-0.37
EV/Revenue (<3 favorable)
N/A
P/S (TTM) (<3 favorable)
N/A
P/B (<3 favorable)
13.32
Ownership
Retail‑heavy
Source: Overview
Insiders (1–5% typical)
38.97%
Institutions (25–75% balanced)
9.58%
Shares Outstanding
28,834,100
Float
19,044,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
0
Gross Profit (TTM)
0
EPS (TTM)
-0.77
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
N/A
ROE (TTM) (>15% strong)
-1.62%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
N/A
Momentum
Bearish momentum
Value
-0.0749
Previous
-0.0681
Trend
Falling
Signal Cross
No cross
As of
Sep. 12, 2025